{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:46:06Z","timestamp":1772689566777,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s11239-012-0758-y","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T10:20:31Z","timestamp":1340878831000},"page":"491-498","source":"Crossref","is-referenced-by-count":35,"title":["Bleeding risk factors associated with argatroban therapy in the critically ill"],"prefix":"10.1007","volume":"34","author":[{"given":"Bruce","family":"Doepker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari L.","family":"Mount","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay J.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire V.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"issue":"5","key":"758_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1H569","volume":"41","author":"M Beiderlinden","year":"2007","unstructured":"Beiderlinden M et al (2007) Argatroban anticoagulation in critically ill patients. Ann Pharmacother 41(5):749\u2013754","journal-title":"Ann Pharmacother"},{"issue":"3","key":"758_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1345\/aph.1A204","volume":"36","author":"WE Dager","year":"2002","unstructured":"Dager WE, White RH (2002) Treatment of heparin-induced thrombocytopenia. Ann Pharmacother 36(3):489\u2013503","journal-title":"Ann Pharmacother"},{"issue":"6 Suppl","key":"758_CR3","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","volume":"133","author":"TE Warkentin","year":"2008","unstructured":"Warkentin TE et al (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):340S\u2013380S","journal-title":"Chest"},{"issue":"4","key":"758_CR4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","volume":"35","author":"K Selleng","year":"2007","unstructured":"Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35(4):1165\u20131176","journal-title":"Crit Care Med"},{"issue":"6 Suppl","key":"758_CR5","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","volume":"133","author":"J Hirsh","year":"2008","unstructured":"Hirsh J et al (2008) Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):141S\u2013159S","journal-title":"Chest"},{"issue":"5","key":"758_CR6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1378\/chest.129.5.1167","volume":"129","author":"RL Levine","year":"2006","unstructured":"Levine RL, Hursting MJ, McCollum D (2006) Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest 129(5):1167\u20131175","journal-title":"Chest"},{"issue":"4","key":"758_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/1120090-000000000-00000","volume":"9","author":"S Dhillon","year":"2009","unstructured":"Dhillon S (2009) Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Am J Cardiovasc Drugs 9(4):261\u2013282","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"758_CR8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1592\/phco.20.4.318.34881","volume":"20","author":"SK Swan","year":"2000","unstructured":"Swan SK, Hursting MJ (2000) The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 20(3):318\u2013329","journal-title":"Pharmacotherapy"},{"issue":"3","key":"758_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200932030-00003","volume":"32","author":"MJ Hursting","year":"2009","unstructured":"Hursting MJ, Soffer J (2009) Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia. Drug Saf Int J Med Toxicol Drug Experience 32(3):203\u2013218","journal-title":"Drug Saf Int J Med Toxicol Drug Experience"},{"key":"758_CR10","unstructured":"Argatroban Package Insert. 2010"},{"issue":"14","key":"758_CR11","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","volume":"103","author":"BE Lewis","year":"2001","unstructured":"Lewis BE et al (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103(14):1838\u20131843","journal-title":"Circulation"},{"issue":"15","key":"758_CR12","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","volume":"163","author":"BE Lewis","year":"2003","unstructured":"Lewis BE et al (2003) Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 163(15):1849\u20131856","journal-title":"Arch Intern Med"},{"issue":"1","key":"758_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1345\/aph.1L224","volume":"43","author":"SP Keegan","year":"2009","unstructured":"Keegan SP et al (2009) Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia. Ann Pharmacother 43(1):19\u201327","journal-title":"Ann Pharmacother"},{"issue":"5","key":"758_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0885066608321246","volume":"23","author":"SM Begelman","year":"2008","unstructured":"Begelman SM et al (2008) Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure. J Intensive Care Med 23(5):313\u2013320","journal-title":"J Intensive Care Med"},{"issue":"9","key":"758_CR15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1592\/phco.29.9.1073","volume":"29","author":"MA Smythe","year":"2009","unstructured":"Smythe MA et al (2009) Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients. Pharmacotherapy 29(9):1073\u20131081","journal-title":"Pharmacotherapy"},{"issue":"3","key":"758_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1345\/aph.1K434","volume":"42","author":"WD Hoffman","year":"2008","unstructured":"Hoffman WD et al (2008) Reduced argatroban doses after coronary artery bypass graft surgery. Ann Pharmacother 42(3):309\u2013316","journal-title":"Ann Pharmacother"},{"issue":"4","key":"758_CR17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694","journal-title":"J Thromb Haemost"},{"issue":"3","key":"758_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2006.06018.x","volume":"133","author":"D Keeling","year":"2006","unstructured":"Keeling D, Davidson S, Watson H (2006) The management of heparin-induced thrombocytopenia. Br J Haematol 133(3):259\u2013269","journal-title":"Br J Haematol"},{"issue":"6","key":"758_CR19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.129.6.1407","volume":"129","author":"BE Lewis","year":"2006","unstructured":"Lewis BE et al (2006) Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 129(6):1407\u20131416","journal-title":"Chest"},{"issue":"4","key":"758_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1076029607303617","volume":"13","author":"A Gray","year":"2007","unstructured":"Gray A et al (2007) Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients. Clin Appl Thromb Hemost 13(4):353\u2013361","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"758_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/FJC.0b013e3181926928","volume":"52","author":"MJ Hursting","year":"2008","unstructured":"Hursting MJ, Verme-Gibboney CN (2008) Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study. J Cardiovasc Pharmacol 52(6):561\u2013566","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"758_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11239-007-0051-7","volume":"25","author":"MJ Hursting","year":"2008","unstructured":"Hursting MJ, Jang I-K (2008) Effect of body mass index on argatroban therapy during percutaneous coronary intervention. J Thromb Thrombolysis 25(3):273\u2013279","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"758_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1L213","volume":"43","author":"AJ Ansara","year":"2009","unstructured":"Ansara AJ, Arif S, Warhurst RD (2009) Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia. Ann Pharmacother 43(1):9\u201318","journal-title":"Ann Pharmacother"},{"issue":"2 Pt 1","key":"758_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/ajrccm.162.2.ncc3-00","volume":"162","author":"RE Drews","year":"2000","unstructured":"Drews RE, Weinberger SE (2000) Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 162(2 Pt 1):347\u2013351","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"758_CR25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","volume":"121","author":"TE Warkentin","year":"2003","unstructured":"Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121(4):535\u2013555","journal-title":"Br J Haematol"},{"issue":"3","key":"758_CR26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1213\/01.ane.0000277497.70701.47","volume":"105","author":"JH Levy","year":"2007","unstructured":"Levy JH, Tanaka KA, Hursting MJ (2007) Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Anesth Analg 105(3):570\u2013582","journal-title":"Anesth Analg"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-012-0758-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0758-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:55Z","timestamp":1559372515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-012-0758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s11239-012-0758-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}